International Journal of Molecular Medicine 2019

5 papers
The International Journal of Molecular Medicine in 2019 focused extensively on the molecular mechanisms driving cancer progression and the identification of therapeutic targets. Research frequently examined intracellular signaling cascades, such as the MEK/ERK and Akt/GSK3β pathways, to understand their roles in cell proliferation, migration, and angiogenesis. Several studies investigated methods to overcome therapeutic resistance in malignancies, exploring how compounds like alantolactone and pristimerin can sensitize lung cancer cells to chemotherapy by modulating reactive oxygen species and autophagy. The year’s publications also highlighted the importance of the tumor microenvironment, specifically how paracrine signaling and macrophage differentiation influence ovarian cancer cell behavior. Beyond oncology, the journal addressed developmental biology through studies on the structural defects in salivary glands resulting from the loss of Fam20c. Methodological trends included the use of comparative transcriptomics, phosphoproteomic mapping, and stable gene silencing to identify phenotypic drivers. Prolific contributors during this period included researchers such as Bin Li, Yingbin Zhang, and Jiansheng Wang, who focused on validating pharmacological pathways and bridging the translational gap in clinical research.

Top Research Directions

The 4 research directions with International Journal of Molecular Medicine 2019 papers, ranked by paper count, next to 2018. Share is the fraction of the edition’s papers in the direction.

#Direction20192018Share 2019Share 20182018 rank
1Cell Type Specific Genetic Ablation for Functional Mapping1020.0%0.0%—
2Decoupling Direct Contact from Paracrine Signaling1120.0%8.3%10
3Physiological Validation of Reductionist Molecular Mechanisms1220.0%16.7%4
4Validating Causal Mechanisms via Pharmacological Pathway Inhibition1120.0%8.3%32

Download all directions as CSV

Institutions

Institutions credited by International Journal of Molecular Medicine 2019 papers: a paper credits every institution named in its affiliations, once. 9 institutions share 3 credited papers.

#InstitutionPapersShare20182018 rank
102h2ywm64 133.3%0—
203r7e8324 133.3%119
303s8txj32 133.3%120
405vy2sc54 133.3%0—
5Peking University 133.3%0—
6Peking University Third Hospital 133.3%0—
7Texas A&M University 133.3%0—
8University of Toronto 133.3%0—
9Xiangya Hospital Central South University 133.3%0—

Download all institutions as CSV

About this data

Papers. International Journal of Molecular Medicine 2019 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2018 use shares, since the edition went from 12 to 5 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 5 papers (60.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Molecular Medicine 2019”, https://lacuna.tiptreesystems.com/venue/international-journal-of-molecular-medicine/2019.

Papers

Title
Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway
Apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages and promote the�proliferation and migration of ovarian cancer�cells by activating the ERK signaling pathway
Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway
Loss of Fam20c causes defects in the acinar and duct structure of salivary glands in mice
Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells